Quality of life after late invasive therapy for occluded arteries. - Wikidata - wikimedia - TriplyDB

Quality of life after late invasive therapy for occluded arteries.

Quality of life after late invasive therapy for occluded arteries.

http://www.wikidata.org/entity/Q37298262

about

Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial.Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT)Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.Depression as a Clinical Determinant of Dependence and Low Quality of Life in Elderly Patients with Cardiovascular Disease.Assessing quality-of-life outcomes in cardiovascular clinical research.A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: a randomized trial in nonemergent patients.Safer cardiac surgery.Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease.Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions.

P2860

Q30429019-D9EE68D9-9DB8-4780-9B08-3B4649CEAA9E Q33431698-5AFFC5FB-D6A4-4130-84C9-F73F6DC7F0D7 Q33548994-A92DC744-5536-41DE-B667-54F8720D4BBC Q33792693-4EF9C59A-0DFF-4D65-8E40-61615FA96FAF Q34242531-7608404F-E87D-44F1-9863-A179EA9B8705 Q35607236-7681CC3F-9A7D-4165-839F-D9097E836C19 Q35794546-ADD89798-BB26-4204-A07D-05559ABF99B2 Q38737960-03BB8A3D-ADA3-43BA-B432-357F336A2781 Q39291162-3658A24F-FA7B-45D9-806D-CE1ECE98A0FC Q39678262-A11297AD-AD3A-413F-B6B0-D1C969571590 Q46376967-6C656854-70FE-421B-869D-63AD20708E82 Q48002756-34C5C093-3CD3-4E47-8655-E99A016D6207

P2860

Quality of life after late invasive therapy for occluded arteries.

http://www.wikidata.org/entity/Q37298262

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Quality of life after late invasive therapy for occluded arteries.

@en

Quality of life after late invasive therapy for occluded arteries.

@nl

type

label

Quality of life after late invasive therapy for occluded arteries.

@en

Quality of life after late invasive therapy for occluded arteries.

@nl

prefLabel

Quality of life after late invasive therapy for occluded arteries.

@en

Quality of life after late invasive therapy for occluded arteries.

@nl

P1433

Q37298262-5BACB651-78F0-412E-9F47-69A3360D66F0

P1476

Q37298262-1134F064-470F-4A24-B8C7-CEADA59D89FC

P2093

Q37298262-04BFA1AD-3612-437F-B706-32CA6B78D94F

Q37298262-11C390B9-A00E-48B8-918E-8443B5E6F109

Q37298262-1C1EF90E-0225-493E-B376-30E704207E23

Q37298262-1DF06DE0-D3CB-4E36-989F-811E55F74CBD

Q37298262-2B755CF0-8009-4C55-9A59-A5886A27F55F

Q37298262-3D8AB5A7-ED9C-4421-A85A-90B74DB34C82

Q37298262-48930D34-C594-4B63-9B82-339DD5B1B379

Q37298262-5D82D095-FFA9-4B3A-8B24-A65EA7F595FC

Q37298262-6EFA95CD-9B3F-4B59-9E46-EC6F8A91BA84

Q37298262-B25A5789-DF75-4A25-9233-5FB4A63AE4C0

P2860

Q37298262-16135B44-597D-401D-94A2-A4049C592862

Q37298262-266C5747-A003-4590-A2D0-254EE5C9FC0F

Q37298262-32B5CBD1-916A-4BB0-A4CA-77E2CFE31F95

Q37298262-6910D64D-6DFF-4320-AD53-ABD2046824C2

Q37298262-73E159F8-1B2C-4E23-8619-99DB761E9FDF

Q37298262-82472CF1-F2C8-4CBE-9691-77A32660EDAF

Q37298262-92B351D1-79A4-4224-852F-114D900C247C

Q37298262-9C1DF615-8EAE-44CD-BCD2-69DCBF233509

Q37298262-D62B90AD-C151-4B19-A81B-8902F273B74C

Q37298262-D8AAB1FC-DBAD-4578-AA17-ECB52FE0BB75

P304

Q37298262-FAFA50B0-441A-4467-A049-0E021828669E

P31

Q37298262-55CDE80F-204F-49AC-B5DF-85EE31FFD246

P356

Q37298262-A7AF27D3-0684-42E8-9D75-B05268B92E28

P407

Q37298262-AA406C7F-7D08-40B1-943F-F7042879DCCD

P433

Q37298262-E0044901-021C-4493-A5F7-F60ABC89697D

P478

Q37298262-ED0C5FFA-CF76-4531-AB0D-7B7FCE80EB72

P50

Q37298262-30376077-B3F1-4230-9F08-E93328B3CA13

Q37298262-4417A868-0A44-43D7-8491-C86F76028807

Q37298262-8A6C151E-6F9A-4056-A2F7-81F1F58067B1

Q37298262-C1E70B9E-A140-4507-BB07-47BD36D568AD

Q37298262-E07E9CBD-CF25-4FCC-8D7A-9B6FB2520A58

P577

Q37298262-D239E63D-C53E-4C02-ADFE-59A9FD3114A4

P5875

Q37298262-66E63300-E19C-407B-B27B-D2B9363CE541

P698

Q37298262-32058031-E268-4597-A803-A395BAF7DCB2

P921

Q37298262-1F0E24F1-32EA-453D-A13D-6C66177FBB32

P932

Q37298262-0D9C720A-EEE3-48BB-9997-634459F3A4D1

P356

P1433

The New England Journal of Medicine

P1476

Quality of life after late invasive therapy for occluded arteries.

@en

P2093

C Edwin Martin

http://www.w3.org/2001/XMLSchema#string

Christopher Adlbrecht

http://www.w3.org/2001/XMLSchema#string

Eric A Cohen

http://www.w3.org/2001/XMLSchema#string

Gerard P Devlin

http://www.w3.org/2001/XMLSchema#string

John R Ross

http://www.w3.org/2001/XMLSchema#string

Linda Davidson Ray

http://www.w3.org/2001/XMLSchema#string

Occluded Artery Trial Investigators

http://www.w3.org/2001/XMLSchema#string

Patricia A Cowper

http://www.w3.org/2001/XMLSchema#string

Rebecca S Fox

http://www.w3.org/2001/XMLSchema#string

Wenqin Pan

http://www.w3.org/2001/XMLSchema#string

P2860

Quality of life with defibrillator therapy or amiodarone in heart failure

Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes.

Medical economics and the assessment of value in cardiovascular medicine: Part I.

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Measurement of health state utilities for economic appraisal.

Coronary intervention for persistent occlusion after myocardial infarction

Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME).

Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial.

Initial functional and economic status of patients with multivessel coronary artery disease randomized in the Bypass Angioplasty Revascularization Investigation (BARI).

Effect of PCI on quality of life in patients with stable coronary disease.

P304

774-783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0805151

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Judith S Hochman

Kevin J Anstrom

Nancy Clapp-Channing

Gervasio A Lamas

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24026513

http://www.w3.org/2001/XMLSchema#string

P698

19228620

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

2724193

http://www.w3.org/2001/XMLSchema#string